Michelle R. Arkin, Ph.D. Dr. Arkin received her B.A. degree in chemistry from Bryn Mawr College and her Ph.D. in chemistry at Caltech with Dr. Jacqueline Barton. In 2005 she became the Associate Director of Cell Biology at Sunesis and led the translational science team for Voreloxin, an anti-cancer agent in phase 2 clinical trials. Since July 2007, Michelle has been the Associate Director of Biology at the Small Molecule Discovery Center (http://smdc.ucsf.edu) and Adjunct Assistant Professor in the Department of Pharmaceutical Chemistry at UCSF.
In 2005 she became the Associate Director of Cell Biology at Sunesis and led the translational science team for Voreloxin, an anti-cancer agent in phase 2 clinical trials. Since July 2007, Michelle has been the Associate Director of Biology at the Small Molecule Discovery Center (http://smdc.ucsf.edu) and Adjunct Assistant Professor in the Department of Pharmaceutical Chemistry at UCSF. In this capacity, she directs the high-throughput screening facility and engages in grant-funded drug discovery research. Dr. Arkin’s research interests are in seeking innovative approaches to tackle “undruggable” targets such as protein-protein interfaces and allosteric interactions.
